AMD Advanced Micro Devices Inc.

2nd Gen AMD EPYCâ„¢ Processors Now Delivering More Computing Power to Amazon Web Services Customers

2nd Gen AMD EPYC™ Processors Now Delivering More Computing Power to Amazon Web Services Customers

Amazon Web Services adds 2nd Gen AMD EPYC processor powered instances, providing customers high performance processing for compute intensive workloads

SANTA CLARA, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: AMD) today announced that 2nd Gen AMD EPYC™ processor powered Amazon Elastic Compute Cloud (EC2) C5a instances are now generally available in the AWS U.S. East, AWS U.S. West, AWS Europe and AWS Asia Pacific regions.

Powered by a 2nd Gen AMD EPYC processor running at frequencies up to 3.3Ghzi, the Amazon EC2 C5a instances are the sixth instance family at AWS powered by AMD EPYC processors. By using the 2nd Gen AMD EPYC processor, the C5a instance delivers leadership x86 price-performance for a broad set of compute-intensive workloads including batch processing, distributed analytics, data transformations, log analytics and web applications.

Available in eight configurations, with up to 96 virtual CPUs, the Amazon EC2 C5a instances take advantage of high core counts from the AMD EPYC processor to offer the . This provides customers with an additional choice for optimal performance and cost across a variety of compute intensive workloads, including video game development and hosting which take advantage of the high CPU core counts and memory ratios provided by C5a.

“The 2nd Gen AMD EPYC processors deliver the levels of performance required for our customers to confidently bring compute-focused workloads to the cloud,” said Forrest Norrod, senior vice president and general manager, Data Center and Embedded Solutions Group, AMD. “With the new Amazon EC2 C5a instances, we are strategically expanding our presence and capabilities with AWS. Even more importantly, together we are helping to continuously improve the end user cloud experience.”

“Together, AMD and AWS offer customers great flexibility and choice of compute options to help them optimize both performance and cost for a wide range of workloads,” said David Brown, Vice President, Amazon EC2, Amazon Web Services, Inc. “Since launching Amazon EC2 R5a, M5a, and T3a instances powered by 1st gen AMD EPYC processors, we’ve seen customers move many general purpose and memory optimized workloads to take advantage of the AMD EPYC processor capabilities and 10% lower prices over comparable instances. With the availability of Amazon EC2 C5a instances based on the 2nd gen AMD EPYC processors, customers now have a new option that enables better performance and cost for a variety of compute intensive workloads, as well.”

AMD and AWS have provided customers with high performance, cost effective options since early 2018 with five Amazon EC2 instance families ( and ) spanning more than 15 global AWS Regions. The new Amazon EC2 C5a instances with 2nd Gen AMD EPYC™ processors are available now in the AWS U.S. East, AWS U.S. West, AWS Europe, and AWS Asia Pacific regions. Disk variants, Amazon EC2 C5ad, that come with local NVMe instance storage and bare metal variants, Amazon EC2 C5an.metal and Amazon EC2 C5adn.metal, are coming soon.

The AWS compute optimized EC2 instances are a direct result of the ongoing collaboration between AWS and AMD. Read more about the 2nd Gen AMD EPYC™ processor and AWS’s EC2 Instance general availability .  

Supporting Resources

  • Read more about C5a in the AWS blog

  • Learn more about the

  • Become a fan of AMD on

  • Follow AMD on

About AMD

For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) , , and pages.

AMD, the AMD Arrow logo, EPYC and combinations thereof, are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

i Max boost for AMD EPYC processors is the maximum frequency achievable by any single core on the processor under normal operating conditions for server systems. EPYC-18

Contact:
Aaron Grabein
AMD Communications
(512) 602-8950
 

Laura Graves
AMD Investor Relations
(408) 749-5467
 
EN
04/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Advanced Micro Devices Inc.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NKTR NEKTAR THERAPEUTICS
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
ACRS ACLARIS THERAPEUTICS INC.
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ORIC KEROS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
SANA VIRIDIAN THERAPEUTICS INC
PLTK SANA BIOTECHNOLOGY
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
PEPG TYRA BIOSCIENCES INC
EWTX PEPGEN INC
SLDB EDGEWISE THERAPEUTICS INC
DDI SOLID BIOSCIENCES INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B APOGEE THERAPEUTICS INC
DNTH EMBRACER GROUP AB
ORKA DIANTHUS THERAPEUTICS INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
IMA JADE BIOSCIENCES INC
IMAGENEBIO INC.
Pierre FerraguÊ
  • Pierre FerraguÊ

The Tech Infrastructure Quarterly Bible 4Q25

​​​​We publish today our comprehensive quarterly bible: 243 pages of detailed analyses on what happened in the last 3 months, and how we interpret it, in light of our current convictions. The first section acts as a PM summary, outlining our key findings, and latest thoughts on the semi cycle, in 6 slides:

ResearchPool Subscriptions

Get the most out of your insights

Get in touch